Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1995 Apr;146(4):924–932.

Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins.

V Buée-Scherrer 1, L Buée 1, P R Hof 1, B Leveugle 1, C Gilles 1, A J Loerzel 1, D P Perl 1, A Delacourte 1
PMCID: PMC1869250  PMID: 7717459

Abstract

Neurofibrillary tangles are observed in several neurodegenerative disorders including Alzheimer's disease, progressive supranuclear palsy, and amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. The major components of neurofibrillary tangles are hyperphosphorylated tau proteins that can be directly detected in brain homogenates, using immunoblotting with specific immunological probes. To investigate whether tau proteins differ biochemically among various neurodegenerative disorders, we analyzed a series of brain samples from Guamanian patients in comparison with Alzheimer's disease, progressive supranuclear palsy, and normal aging. In Alzheimer's disease, these hyperphosphorylated tau proteins are composed of a triplet referred to as tau 55, 64, and 69, whereas in progressive supranuclear palsy, neurofibrillary degeneration is characterized by a tau doublet (tau 64 and 69). In the present study, characterization of tau proteins was performed by immunoblotting, on different cortical and subcortical regions of postmortem brain specimens from Guamanian natives. In all of the cases, biochemical data were always consistent with neuropathological findings. In contrast to Alzheimer's disease patients where the tau triplet is found mostly in cortical regions, a similar triplet was strongly detected in both cortical and subcortical areas in Guamanian patients. The tau profile differed quantitatively from case to case demonstrating that the Alzheimer's disease-related tau triplet had a heterogeneous regional distribution. These data suggest that the tau triplet found in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam is similar to that observed in Alzheimer's disease, and the regional distribution of tau proteins differs in these disorders.

Full text

PDF

Images in this article

927Figure 1
on p.927
928Figure 2
on p.928
928Figure 3
on p.928
929Figure 4
on p.929
929Figure 5
on p.929

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biernat J., Mandelkow E. M., Schröter C., Lichtenberg-Kraag B., Steiner B., Berling B., Meyer H., Mercken M., Vandermeeren A., Goedert M. The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J. 1992 Apr;11(4):1593–1597. doi: 10.1002/j.1460-2075.1992.tb05204.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Binder L. I., Frankfurter A., Rebhun L. I. The distribution of tau in the mammalian central nervous system. J Cell Biol. 1985 Oct;101(4):1371–1378. doi: 10.1083/jcb.101.4.1371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bouras C., Hof P. R., Morrison J. H. Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes. Neurosci Lett. 1993 Apr 30;153(2):131–135. doi: 10.1016/0304-3940(93)90305-5. [DOI] [PubMed] [Google Scholar]
  4. Bramblett G. T., Trojanowski J. Q., Lee V. M. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins). Lab Invest. 1992 Feb;66(2):212–222. [PubMed] [Google Scholar]
  5. Brody J. A., Stanhope J. M., Kurland L. T. Patterns of Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia on Guam. Contemp Neurol Ser. 1975;12:45–70. [PubMed] [Google Scholar]
  6. Corder E. H., Saunders A. M., Risch N. J., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Jr, Rimmler J. B., Locke P. A., Conneally P. M., Schmader K. E. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994 Jun;7(2):180–184. doi: 10.1038/ng0694-180. [DOI] [PubMed] [Google Scholar]
  7. Defossez A., Beauvillain J. C., Delacourte A., Mazzuca M. Alzheimer's disease: a new evidence for common epitopes between microtubule associated protein Tau and paired helical filaments (PHF): demonstration at the electron microscope level by a double immunogold labelling. Virchows Arch A Pathol Anat Histopathol. 1988;413(2):141–145. doi: 10.1007/BF00749675. [DOI] [PubMed] [Google Scholar]
  8. Delacourte A., Defossez A. Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments. J Neurol Sci. 1986 Dec;76(2-3):173–186. doi: 10.1016/0022-510x(86)90167-x. [DOI] [PubMed] [Google Scholar]
  9. Delacourte A., Flament S., Dibe E. M., Hublau P., Sablonnière B., Hémon B., Shérrer V., Défossez A. Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins. Acta Neuropathol. 1990;80(2):111–117. doi: 10.1007/BF00308912. [DOI] [PubMed] [Google Scholar]
  10. Elizan T. S., Hirano A., Abrams B. M., Need R. L., Van Nuis C., Kurland L. T. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam. Neurological reevaluation. Arch Neurol. 1966 Apr;14(4):356–368. doi: 10.1001/archneur.1966.00470100012002. [DOI] [PubMed] [Google Scholar]
  11. Flament S., Delacourte A., Hémon B., Défossez A. Characterization of two pathological tau protein, variants in Alzheimer brain cortices. J Neurol Sci. 1989 Sep;92(2-3):133–141. doi: 10.1016/0022-510x(89)90131-7. [DOI] [PubMed] [Google Scholar]
  12. Flament S., Delacourte A., Verny M., Hauw J. J., Javoy-Agid F. Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol. 1991;81(6):591–596. doi: 10.1007/BF00296367. [DOI] [PubMed] [Google Scholar]
  13. Garruto R. M., Fukatsu R., Yanagihara R., Gajdusek D. C., Hook G., Fiori C. E. Imaging of calcium and aluminum in neurofibrillary tangle-bearing neurons in parkinsonism-dementia of Guam. Proc Natl Acad Sci U S A. 1984 Mar;81(6):1875–1879. doi: 10.1073/pnas.81.6.1875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Garruto R. M. Pacific paradigms of environmentally-induced neurological disorders: clinical, epidemiological and molecular perspectives. Neurotoxicology. 1991 Fall;12(3):347–377. [PubMed] [Google Scholar]
  15. Garver T. D., Harris K. A., Lehman R. A., Lee V. M., Trojanowski J. Q., Billingsley M. L. Tau phosphorylation in human, primate, and rat brain: evidence that a pool of tau is highly phosphorylated in vivo and is rapidly dephosphorylated in vitro. J Neurochem. 1994 Dec;63(6):2279–2287. doi: 10.1046/j.1471-4159.1994.63062279.x. [DOI] [PubMed] [Google Scholar]
  16. Giannakopoulos P., Hof P. R., Giannakopoulos A. S., Buée-Scherrer V., Surini M., Delacourte A., Bouras C. Dementia in the oldest-old: quantitative analysis of 12 cases from a psychiatric hospital. Dementia. 1994 Nov-Dec;5(6):348–356. doi: 10.1159/000106745. [DOI] [PubMed] [Google Scholar]
  17. Greenberg S. G., Davies P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci U S A. 1990 Aug;87(15):5827–5831. doi: 10.1073/pnas.87.15.5827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hirano A., Arumugasamy N., Zimmerman H. M. Amyotrophic lateral sclerosis. A comparison of Guam and classical cases. Arch Neurol. 1967 Apr;16(4):357–363. doi: 10.1001/archneur.1967.00470220021003. [DOI] [PubMed] [Google Scholar]
  19. Hirano A., Arumugasamy N., Zimmerman H. M. Amyotrophic lateral sclerosis. A comparison of Guam and classical cases. Arch Neurol. 1967 Apr;16(4):357–363. doi: 10.1001/archneur.1967.00470220021003. [DOI] [PubMed] [Google Scholar]
  20. Hirano A., Dembitzer H. M., Kurland L. T., Zimmerman H. M. The fine structure of some intraganglionic alterations. Neurofibrillary tangles, granulovacuolar bodies and "rod-like" structures as seen in Guam amyotrophic lateral sclerosis and parkinsonism-dementia complex. J Neuropathol Exp Neurol. 1968 Apr;27(2):167–182. [PubMed] [Google Scholar]
  21. Hirano A., Malamud N., Elizan T. S., Kurland L. T. Amyotrophic lateral sclerosis and Parkinsonism-dementia complex on Guam. Further pathologic studies. Arch Neurol. 1966 Jul;15(1):35–51. doi: 10.1001/archneur.1966.00470130039004. [DOI] [PubMed] [Google Scholar]
  22. Hof P. R., Cox K., Morrison J. H. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex. J Comp Neurol. 1990 Nov 1;301(1):44–54. doi: 10.1002/cne.903010105. [DOI] [PubMed] [Google Scholar]
  23. Hof P. R., Nimchinsky E. A., Buée-Scherrer V., Buée L., Nasrallah J., Hottinger A. F., Purohit D. P., Loerzel A. J., Steele J. C., Delacourte A. Amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam: quantitative neuropathology, immunohistochemical analysis of neuronal vulnerability, and comparison with related neurodegenerative disorders. Acta Neuropathol. 1994;88(5):397–404. doi: 10.1007/BF00389490. [DOI] [PubMed] [Google Scholar]
  24. Hof P. R., Perl D. P., Loerzel A. J., Morrison J. H. Neurofibrillary tangle distribution in the cerebral cortex of parkinsonism-dementia cases from Guam: differences with Alzheimer's disease. Brain Res. 1991 Nov 15;564(2):306–313. doi: 10.1016/0006-8993(91)91467-f. [DOI] [PubMed] [Google Scholar]
  25. Hof P. R., Perl D. P., Loerzel A. J., Steele J. C., Morrison J. H. Amyotrophic lateral sclerosis and parkinsonism-dementia from Guam: differences in neurofibrillary tangle distribution and density in the hippocampal formation and neocortex. Brain Res. 1994 Jul 4;650(1):107–116. doi: 10.1016/0006-8993(94)90212-7. [DOI] [PubMed] [Google Scholar]
  26. Ksiezak-Reding H., Morgan K., Mattiace L. A., Davies P., Liu W. K., Yen S. H., Weidenheim K., Dickson D. W. Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am J Pathol. 1994 Dec;145(6):1496–1508. [PMC free article] [PubMed] [Google Scholar]
  27. Kurland L. T. Amyotrophic lateral sclerosis and Parkinson's disease complex on Guam linked to an environmental neurotoxin. Trends Neurosci. 1988 Feb;11(2):51–54. doi: 10.1016/0166-2236(88)90163-4. [DOI] [PubMed] [Google Scholar]
  28. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  29. Lee V. M., Balin B. J., Otvos L., Jr, Trojanowski J. Q. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science. 1991 Feb 8;251(4994):675–678. doi: 10.1126/science.1899488. [DOI] [PubMed] [Google Scholar]
  30. Lee V. M., Trojanowski J. Q. The disordered neuronal cytoskeleton in Alzheimer's disease. Curr Opin Neurobiol. 1992 Oct;2(5):653–656. doi: 10.1016/0959-4388(92)90034-i. [DOI] [PubMed] [Google Scholar]
  31. Leveugle B., Spik G., Perl D. P., Bouras C., Fillit H. M., Hof P. R. The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis. Brain Res. 1994 Jul 4;650(1):20–31. doi: 10.1016/0006-8993(94)90202-x. [DOI] [PubMed] [Google Scholar]
  32. Lichtenberg-Kraag B., Mandelkow E. M., Biernat J., Steiner B., Schröter C., Gustke N., Meyer H. E., Mandelkow E. Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5384–5388. doi: 10.1073/pnas.89.12.5384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Matsuo E. S., Shin R. W., Billingsley M. L., Van deVoorde A., O'Connor M., Trojanowski J. Q., Lee V. M. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron. 1994 Oct;13(4):989–1002. doi: 10.1016/0896-6273(94)90264-x. [DOI] [PubMed] [Google Scholar]
  34. Perl D. P., Gajdusek D. C., Garruto R. M., Yanagihara R. T., Gibbs C. J. Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Science. 1982 Sep 10;217(4564):1053–1055. doi: 10.1126/science.7112111. [DOI] [PubMed] [Google Scholar]
  35. Shankar S. K., Yanagihara R., Garruto R. M., Grundke-Iqbal I., Kosik K. S., Gajdusek D. C. Immunocytochemical characterization of neurofibrillary tangles in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Ann Neurol. 1989 Feb;25(2):146–151. doi: 10.1002/ana.410250207. [DOI] [PubMed] [Google Scholar]
  36. Spencer P. S. Guam ALS/parkinsonism-dementia: a long-latency neurotoxic disorder caused by "slow toxin(s)" in food? Can J Neurol Sci. 1987 Aug;14(3 Suppl):347–357. doi: 10.1017/s0317167100037732. [DOI] [PubMed] [Google Scholar]
  37. Sternberger N. H., Sternberger L. A., Ulrich J. Aberrant neurofilament phosphorylation in Alzheimer disease. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4274–4276. doi: 10.1073/pnas.82.12.4274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Strittmatter W. J., Weisgraber K. H., Goedert M., Saunders A. M., Huang D., Corder E. H., Dong L. M., Jakes R., Alberts M. J., Gilbert J. R. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol. 1994 Feb;125(2):163–174. doi: 10.1006/exnr.1994.1019. [DOI] [PubMed] [Google Scholar]
  39. Vermersch P., Frigard B., David J. P., Fallet-Bianco C., Delacourte A. Presence of abnormally phosphorylated Tau proteins in the entorhinal cortex of aged non-demented subjects. Neurosci Lett. 1992 Sep 14;144(1-2):143–146. doi: 10.1016/0304-3940(92)90736-q. [DOI] [PubMed] [Google Scholar]
  40. Vermersch P., Frigard B., Delacourte A. Mapping of neurofibrillary degeneration in Alzheimer's disease: evaluation of heterogeneity using the quantification of abnormal tau proteins. Acta Neuropathol. 1992;85(1):48–54. doi: 10.1007/BF00304633. [DOI] [PubMed] [Google Scholar]
  41. Vermersch P., Robitaille Y., Bernier L., Wattez A., Gauvreau D., Delacourte A. Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement. Acta Neuropathol. 1994;87(6):572–577. doi: 10.1007/BF00293317. [DOI] [PubMed] [Google Scholar]
  42. Waring S. C., O'Brien P. C., Kurland L. T., Thibodeau S. N., Tsai M. S., Petersen R. C., Esteban-Santillan C. E. Apolipoprotein E allele in Chamorros with amyotrophic lateral sclerosis/parkinsonism-dementia complex. Lancet. 1994 Mar 5;343(8897):611–611. doi: 10.1016/s0140-6736(94)91568-7. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES